Trevena (TRVN) Tops Q2 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. SPY
9. SBUX
10. AXP

Go back to Trevena (TRVN) Tops Q2 EPS by 1c

Trevena Reports Second Quarter 2022 Results and Provides Business Update

August 11, 2022 7:00 AM EDT

OLINVYK post-approval strategy advances with positive topline cognitive function data and continued enrollment in VOLITION clinical outcomes study

Phase 1 study for TRV045, a novel S1P receptor modulator, on track for year-end data readout; single ascending dose and food effect study segments fully enrolled

TRV045 demonstrated potential antiepileptic effect in multiple preclinical models

Cash balance of $49.5 million at Q2 provides cash runway to mid-2023 with previously announced strategic allocation of resources and cost reductions

Company to host conference call today, August 11,... More